Literature DB >> 16003400

Porous scaffold design for tissue engineering.

Scott J Hollister1.   

Abstract

A paradigm shift is taking place in medicine from using synthetic implants and tissue grafts to a tissue engineering approach that uses degradable porous material scaffolds integrated with biological cells or molecules to regenerate tissues. This new paradigm requires scaffolds that balance temporary mechanical function with mass transport to aid biological delivery and tissue regeneration. Little is known quantitatively about this balance as early scaffolds were not fabricated with precise porous architecture. Recent advances in both computational topology design (CTD) and solid free-form fabrication (SFF) have made it possible to create scaffolds with controlled architecture. This paper reviews the integration of CTD with SFF to build designer tissue-engineering scaffolds. It also details the mechanical properties and tissue regeneration achieved using designer scaffolds. Finally, future directions are suggested for using designer scaffolds with in vivo experimentation to optimize tissue-engineering treatments, and coupling designer scaffolds with cell printing to create designer material/biofactor hybrids.

Mesh:

Substances:

Year:  2005        PMID: 16003400     DOI: 10.1038/nmat1421

Source DB:  PubMed          Journal:  Nat Mater        ISSN: 1476-1122            Impact factor:   43.841


  523 in total

1.  Effects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo.

Authors:  Eiji Saito; Elly E Liao; Wei-Wen Hu; Paul H Krebsbach; Scott J Hollister
Journal:  J Tissue Eng Regen Med       Date:  2011-12-09       Impact factor: 3.963

2.  Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds.

Authors:  Gary A Fielding; Amit Bandyopadhyay; Susmita Bose
Journal:  Dent Mater       Date:  2011-11-01       Impact factor: 5.304

Review 3.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

4.  Processing and characterization of innovative scaffolds for bone tissue engineering.

Authors:  D Bellucci; F Chiellini; G Ciardelli; M Gazzarri; P Gentile; A Sola; V Cannillo
Journal:  J Mater Sci Mater Med       Date:  2012-03-23       Impact factor: 3.896

5.  Enhanced cell ingrowth and proliferation through three-dimensional nanocomposite scaffolds with controlled pore structures.

Authors:  Kee-Won Lee; Shanfeng Wang; Mahrokh Dadsetan; Michael J Yaszemski; Lichun Lu
Journal:  Biomacromolecules       Date:  2010-03-08       Impact factor: 6.988

6.  Maintaining cell depth viability: on the efficacy of a trimodal scaffold pore architecture and dynamic rotational culturing.

Authors:  Conor Timothy Buckley; Kevin Unai O'Kelly
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

Review 7.  Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression.

Authors:  Kyobum Kim; Andrew Yeatts; David Dean; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

8.  Design of Injectable Materials to Improve Stem Cell Transplantation.

Authors:  Laura M Marquardt; Sarah C Heilshorn
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

9.  Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds.

Authors:  Sungsoo S Lee; Brian J Huang; Stuart R Kaltz; Shantanu Sur; Christina J Newcomb; Stuart R Stock; Ramille N Shah; Samuel I Stupp
Journal:  Biomaterials       Date:  2012-10-23       Impact factor: 12.479

10.  Application of visible light-based projection stereolithography for live cell-scaffold fabrication with designed architecture.

Authors:  Hang Lin; Dongning Zhang; Peter G Alexander; Guang Yang; Jian Tan; Anthony Wai-Ming Cheng; Rocky S Tuan
Journal:  Biomaterials       Date:  2012-10-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.